Routine Bladder Catheterisation Through Fast-track Hip and Knee Replacement - What Are the Consequences?
NCT ID: NCT02133768
Last Updated: 2017-03-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
800 participants
OBSERVATIONAL
2014-05-31
2016-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
When to Perform Bladder Catheterization in Fast-track Hip and Knee Arthroplasty
NCT02126813
Recovery at the Post Anaesthetic Care Unit After Hip and Knee Arthroplasty
NCT01178489
Recovery After Fast Track THA / TKA
NCT02137655
Fast-Track vs Conventional for UKA
NCT00284635
Rehabilitation After Fast-track Total Knee Arthroplasty
NCT01329081
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
It was previously standard to use fixed urinary catheter (KAD), the first 24-48 hours postoperatively to prevent POUR by THA and TKA, while more recent studies now recommend intermittent urinary catheterization in the postoperative period.
However, there are no detailed studies with adequate follow-up, describing the consequences of using either one or the other treatment regimen of POUR by fast-track THA and TKA.
Purpose:
To describe the need for re-catheterization and incidence of urological complications of routine use of perioperative fixed urinary catheter (KAD,catheter a demure) for up to 24 hours of fast-track THA and TKA
End Points:
1. The number of patients in need of re-catheterization due POUR
2. The number of patients in which the removal of KAD was not carried out within 24 hours.
3. The number of urinary tract infections from surgery to postoperative day (POD) 30
4. The number of patients with new-onset urinary discomfort at POD 30 (Increase in IPSS score).
5. The number of urological-related readmissions (including urosepsis) within POD 30
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \>50 years.
* Patients scheduled for primary THA or TKA.
* Patients who have given verbal consent to participate in the study.
Exclusion Criteria
* Patients who can not cooperate with the study.
* Patients who do not understand or speak Danish.
* Patients who are permanent catheter carriers or use disposable bladder catheterisation.
* Patients on hemodialysis.
* Urine Derivative patients.
* Pregnancy or childbirth within 6 months.
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Lundbeck Foundation
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Homilius
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Morten Homilius
Role: PRINCIPAL_INVESTIGATOR
Department of orthopedic, Regional Hospital Holstebro
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Orthopedic
Holstebro, Central Jutland, Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bjerregaard LS, Homilius M, Bagi P, Hansen TB, Kehlet H. Indwelling urinary catheterisation may increase risk of complications in hip and knee arthroplasty. Dan Med J. 2019 Apr;66(4):A5538.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Lundbeck Foundation
Identifier Type: OTHER
Identifier Source: secondary_id
Bladder cathererisation
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.